SheBoot

Atorvia is pioneering novel therapeutic approaches for organ failure, starting in the kidney. Targeting a previously unknown functional role of a protein involved in the regulated cell death pathway, Atorvia’s lead program is a small peptide therapeutic that prevents and treats kidney failure caused by ischemia. Potential applications of this first-in-class drug include preventing kidney failure in patients undergoing surgery, a common and often devastating consequence during transplant or cardiac bypass procedures. There is currently nothing surgeons can do to prevent it and no treatment for it.

FemTherapeutics Inc. is a Montreal-based medical device company focused on personalizing therapeutics in women’s health. The company has developed an artificial intelligence platform that utilizes patient data and three-dimensional printing technology to create customizable gynecological prosthetics, specifically designed for the management of Pelvic Floor Disorders. Their innovative approach aims to improve the clinical outcomes for women suffering from conditions such as pelvic organ prolapse and stress urinary incontinence, providing non-invasive solutions that enhance quality of life through effective symptom relief. FemTherapeutics’ commitment to leveraging advanced technology positions it at the forefront of women's health innovation.

FemTherapeutics Inc. is a Montreal-based medical device company focused on personalizing therapeutics in women’s health. The company has developed an artificial intelligence platform that utilizes patient data and three-dimensional printing technology to create customizable gynecological prosthetics, specifically designed for the management of Pelvic Floor Disorders. Their innovative approach aims to improve the clinical outcomes for women suffering from conditions such as pelvic organ prolapse and stress urinary incontinence, providing non-invasive solutions that enhance quality of life through effective symptom relief. FemTherapeutics’ commitment to leveraging advanced technology positions it at the forefront of women's health innovation.

Viridis Research is a water treatment and recycling company focused on addressing systemic socio-economic water issues. The company specializes in greywater recycling technology, which aims to significantly reduce water consumption. It processes water from sinks, showers, baths, and washing machines at its treatment center, where larger particles are removed. The remaining organic and polymer-based pollutants are completely degraded using an electrochemical reactor. This innovative approach allows clients to utilize purified water immediately for applications such as toilet flushing or to store it for land irrigation and firefighting, all without the need for additional chemicals or the production of solid and liquid waste.

ImaginAble Solutions specializes in the development of assistive devices aimed at enhancing the quality of life for individuals with impaired motor movement due to medical conditions or injuries. The company's innovative devices are designed to address limitations in hand mobility, facilitating activities such as writing, painting, drawing, and using tablets or computers. By promoting guided and controlled hand movements, ImaginAble Solutions' products help users reduce pain and hand fatigue, thereby improving their overall functionality and independence.

Haloo is a company focused on democratizing brand protection by providing a comprehensive platform designed for marketing and legal teams. This innovative tool streamlines the trademark management process, allowing users to efficiently search, file, and defend trademarks in a single workspace. By offering instant professional trademark searches, fail-safe application processes, and automated brand enforcement, Haloo addresses the challenges of trademark vetting, which can often be slow, costly, and prone to errors. The platform is continuously updated to reflect changes in trademark law, ensuring that clients have access to the latest practices. Additionally, Haloo's tools are adaptable for the Web3 environment, enabling users to detect counterfeit or copycat NFTs and protect their intellectual property effectively.